Pancreatic Cancer Action
||This article contains content that is written like an advertisement. (January 2017) (Learn how and when to remove this template message)|
|Registration no.||England and Wales: 1137689|
|Focus||pancreatic cancer, Cancer research, Health policy|
|Slogan||Saving lives through earlier diagnosis|
|Mission||TO IMPROVE SURVIVAL FOR PANCREATIC CANCER PATIENTS THROUGH EARLIER DIAGNOSIS|
Founded by Ali Stunt, who is herself a rare survivor of the disease, Pancreatic Cancer Action is dedicated to saving lives. The five-year survival rate for pancreatic cancer is only around 5% – this figure has not improved in over 40 years.
Pancreatic cancer is the fifth-commonest cause of cancer death in the UK yet receives only 1% of research funding. Only 10% of patients with a diagnosis of pancreatic cancer are able to have potentially curative surgery.
- Mission: To change pancreatic cancer survival numbers
- Focus: To improve early detection statistics
- Approach: To increase awareness of pancreatic cancer to the public, the medical community and Government
One focus is the annual UK Pancreatic Cancer Awareness Month held in November each year.
Having been involved in setting up the very first Pancreatic Cancer Awareness Week in 2009, Ali Stunt decided it was time to step up the levels of awareness for pancreatic cancer and so founded Pancreatic Cancer Action.
Along with Stunt, Pancreatic Cancer Action has the support of many leading clinicians and researchers in the pancreatic cancer field, along with others whose lives have been touched by pancreatic cancer in some way.
- Alison Stunt – Founder & CEO
- Natasha North - Marketing and Communications Manager
- Lucy Delemos - Fundraising Manager
- Vicky McLaren - Information and Operations Manager
- Lu Constable - Marketing Executive
- Holly Gardner - Fundraising Assistant
- Lisl Haldenwang - Office Manager
- Gemma Brown - Administration Assistant
- Issy Smith - Fundraising Communications Assistant
- Phil Stunt – Chair
- Helen Matthews – Secretary & Fundraising
- Jane McCue – Treasurer
- Charlotte Maude – Marketing/PR
- Neville Menezes – Consultant Pancreatic Surgeon
- Carolyn Scott – Medical Liaison
- Mr Ross Carter – Glasgow Royal Infirmary (surgical)
- Dr. Seb Cummins – Royal Surrey County Hospital, Guildford (clinical oncology)
- Mr Hemant Kocher – Barts and London (surgical)
- Mr Neville Menezes – Royal Surrey County Hospital, Guildford (surgical)
- Dr. Gary Middleton – Royal Surrey County Hospital, Guildford (medical oncology)
- Dr. Kevin Shotliff – Chelsea & Westminster Hospital and Brompton Hospital. Royal Marsden Hospital (endocrinology)
- Stunt, Ali (August 30, 2012). "It's official – I'm now one of the 3% who survive pancreatic cancer". Pancreatic Cancer Action. Retrieved February 24, 2013.
- "Five year analysis of the national cancer research database, 2002-2006". National Cancer Research Institute. 2008.
- White et al., (1999) in Sultana et al. (2007). "Systematic review, including meta-analysis, on the management of locally advanced pancreatic cancer using radiation/combined modal therapy". British Journal of Cancer 96: 1183-1190.
- "UK pancreatic cancer prognosis and survival rates". Pancreatic Cancer Action. Retrieved February 24, 2013.